Impact of health-related quality of life (HRQoL) on short-term mortality in patients with recurrent ovarian, fallopian or peritoneal carcinoma (the NOGGO-AGO QoL Prognosis-Score-Study): results of a meta-analysis in 2209 patients-Reference-Cited by-同舟云学术

Impact of health-related quality of life (HRQoL) on short-term mortality in patients with recurrent ovarian, fallopian or peritoneal carcinoma (the NOGGO-AGO QoL Prognosis-Score-Study): results of a meta-analysis in 2209 patients

Published:2021-04 Issue:2 Volume:6 Page:100081
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Armbrust R.,Richter R.,Woopen H.,Hilpert F.,Harter P.,Sehouli J.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference41 articles.

1. Quality of life predicts overall survival in women with platinum-resistant ovarian cancer: an AURELIA substudy;Roncolato;Ann Oncol,2017

2. Ovarian cancer;Jayson;Lancet,2014

3. Expression III: patients' expectations and preferences regarding physician-patient relationship and clinical management-results of the international NOGGO/ENGOT-ov4-GCIG study in 1830 ovarian cancer patients from European countries;Oskay-Özcelik;Ann Oncol,2018

4. The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer;Carey;Gynecol Oncol,2008

5. Optimizing treatment in recurrent epithelial ovarian cancer;Corrado;Expert Rev Anticancer Ther,2017

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Survival Determinants in Recurrent Ovarian Cancer: The Role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy;Cancers;2024-06-05

2. Hidden in plain sight – Survival consequences of baseline symptom burden in women with recurrent ovarian cancer;Gynecologic Oncology;2024-06

3. Patient-Reported Outcomes in Ovarian Cancer: Facilitating and Enhancing the Reporting of Symptoms, Adverse Events, and Subjective Benefit of Treatment in Clinical Trials and Clinical Practice;Patient Related Outcome Measures;2023-05

4. Validation of a New Prognostic Score in Patients with Ovarian Adenocarcinoma;Medicina;2023-01-26

5. “Like one part of a puzzle” — individualized aromatherapy for women with gynecological cancers in aftercare: results from a qualitative-focused mixed-methods study;Supportive Care in Cancer;2022-12-23